Production (Stage)
ProKidney Corp.
PROK
$0.9776
$0.190624.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 230.00K | 76.00K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 230.00K | 76.00K | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 230.00K | 76.00K | -- | -- | -- |
| SG&A Expenses | 14.36M | 11.87M | 12.40M | 13.65M | 12.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.62M | 51.65M | 43.65M | 43.06M | 40.08M |
| Operating Income | -41.39M | -51.57M | -43.65M | -43.06M | -40.08M |
| Income Before Tax | -37.36M | -46.78M | -43.40M | -38.52M | -35.24M |
| Income Tax Expenses | 591.00K | 1.70M | -2.34M | -56.00K | 98.00K |
| Earnings from Continuing Operations | -37.95M | -48.48M | -41.05M | -38.47M | -35.33M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 21.22M | 27.21M | 23.14M | 25.96M | 25.84M |
| Net Income | -16.73M | -21.28M | -17.91M | -12.51M | -9.49M |
| EBIT | -41.39M | -51.57M | -43.65M | -43.06M | -40.08M |
| EBITDA | -39.79M | -50.00M | -42.16M | -41.79M | -38.97M |
| EPS Basic | -0.13 | -0.17 | -0.14 | -0.16 | -0.16 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.01 | 0.02 | 0.06 |
| EPS Diluted | -0.13 | -0.17 | -0.14 | -0.16 | -0.16 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.01 | 0.02 | 0.06 |
| Average Basic Shares Outstanding | 128.98M | 128.21M | 126.17M | 75.91M | 60.95M |
| Average Diluted Shares Outstanding | 128.98M | 128.21M | 126.17M | 75.91M | 60.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |